ARTICLE | Company News
Neurochem, Select Therap deal
October 8, 2001 7:00 AM UTC
The companies will develop a beta-amyloid vaccine to prevent Alzheimer's disease (AD). XZL will use its Verovax technology to deliver NRM's AD antigens to dendritic cells. ...